On Thursday, Depomed Inc (NASDAQ:DEPO)’s shares declined -0.71% to $26.62.
Depomed, Inc. (DEPO) declared its participation at PAINWeek® 2015, the nation’s largest annual meeting for frontline clinicians in the area of pain administration, to be held September 8-12, 2015 in Las Vegas.
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
Lattice Semiconductor (NASDAQ:LSCC)’s shares dropped -0.47% to $4.23.
Lattice Semiconductor Corporation (LSCC), the leading provider of customizable smart connectivity solutions, recently declared the availability of the ECP5™ Versa development kit to accelerate prototyping and testing of connectivity designs targeted for small cells, microserver, broadband access, and industrial video applications worldwide. The family’s low power consumption, small form factor and low cost make it an ideal connectivity solution and enables design engineers to rapidly add features and functions that complement those delivered by ASICs and ASSPs, reducing development risk and accelerating time-to-market.
To assist customers interested in the ECP5 device family to quickly design and test application prototypes, Lattice has released an ECP5 Versa development kit. The kit lets customers evaluate the connectivity performance of the ECP5 FPGA with a range of standards, counting PCI Express, Gigabit Ethernet, DDR3 and generic SERDES. Lattice also offers several proof-of-concept demos with the ECP5 Versa development kit that can assist customers accelerate prototyping and testing of their designs.
Financial results for the preceding quarter comprised of the financial results of Silicon Image only for the period subsequent to the closing of the acquisition of Silicon Image by the company on March 10, 2015.
Lattice Semiconductor Corporation designs, develops, and markets programmable logic products and related software in Asia, Europe, and the Americas. It offers products based on field programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs) architectures.
At the end of Thursday’s trade, Xoom Corp (NASDAQ:XOOM)‘s shares surged 0.04% to $24.84.
Xoom Corporation (XOOM), a leading digital money transfer provider, recently declared financial results for the second quarter of 2015.
- Revenue for the second quarter was $46.3 million, an enhance of 16% from the second quarter of 2014.
- Gross profit for the second quarter was $33.0 million, an enhance of 23% from the second quarter of 2014.
- GAAP net loss for the second quarter was $2.3 million, or a loss of $0.06 per diluted share, contrast to net income of $1.4 million, or $0.03 per diluted share, for the second quarter of 2014.
- Adjusted EBITDA for the second quarter was $3.9 million, contrast to $5.1 million for the second quarter of 2014.
- Non-GAAP net income per diluted share for the second quarter was $0.06, contrast to net income of $0.09 per diluted share for the second quarter of 2014.
Xoom Corporation provides digital consumer-to-consumer online money transfers services worldwide. The company offers money transfer services over the Internet or through a mobile device on its Website at xoom.com, or through its mobile application, the Xoom App. Its customers send money to family and friends from the United States to 32 countries.
Celanese Corporation (NYSE:CE), ended its Thursday’s trading session with 1.57% gain, and closed at $60.05.
Recently marks the opening of the Celanese Commercial and Technology Center – Mexico, in the region of Querétaro, to serve the expanding Central and South American customer base of Celanese Corporation (CE), a global technology and specialty materials company. The new center will support the automotive, consumer electronics, appliance, medical device, petrochemical and aerospace industries, in addition to original equipment manufacturers and their tier suppliers.
Research and development technologists in the Celanese Commercial and Technology Center – Mexico will work directly with manufacturers interested in product innovations in the growing markets of engineering polymers, food ingredients, adhesives, paints and coatings, and consumer goods. These customers will have greater access to a diverse product and solution portfolio of engineered materials and intermediate chemicals, together with the technologists’ support and technical expertise.
Celanese Corporation, a technology and specialty materials company manufactures and sells value-added chemicals, thermoplastic polymers, and other chemical-based products worldwide. The company’s Advanced Engineered Materials segment develops, produces, and supplies specialty polymers for use in automotive, medical, electronics, and other consumer and industrial applications.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
